Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
J. Norum, J. A. Olsen, E. A. Wist & P. E. Lønning. (2007) Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis. Acta Oncologica 46:2, pages 153-164.
Read now
Read now
Articles from other publishers (5)
Jan Norum, Eli Marie Grindedal, Cecilie Heramb, Inga Karsrud, Sarah Louise Ariansen, Dag Erik Undlien, Ellen Schlichting & Lovise Mæhle. (2018) BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer. ESMO Open 3:3, pages e000328.
Crossref
Crossref
Marieke Krol, Jocé Papenburg, Siok Swan Tan, Werner Brouwer & Leona Hakkaart. (2015) A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. The European Journal of Health Economics 17:4, pages 391-402.
Crossref
Crossref
Ya-Chen Tina Shih, I-Wen Pan & Yi-Wen Tsai. (2009) Information Technology Facilitates Cost-Effectiveness Analysis in Developing Countries. PharmacoEconomics 27:11, pages 947-961.
Crossref
Crossref
Antoinette D.I. van Asselt, Carmen D. Dirksen, Arnoud Arntz & Johan L. Severens. (2008) Difficulties in Calculating Productivity Costs: Work Disability Associated with Borderline Personality Disorder. Value in Health 11:4, pages 637-644.
Crossref
Crossref
Jan Norum, Anne Irene Hagen, Lovise Mæhle, Jaran Apold, John Burn & Pål Møller. (2008) Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: A cost-effectiveness analysis. European Journal of Cancer 44:7, pages 963-971.
Crossref
Crossref